Inflarx Nv (IFRX) Live Share Price, Invest From India

Inflarx Nv Stock Performance

as on January 24, 2026 at 2:29 am IST

Day's Low
Day's High
$0.98
Day's Price Range
$1.03
$1.01
2.97%
Downside
1.98%
Upside
52 Week's Low
52 Week's High
$0.71
52-Week Price Range
$2.77
$1.01
29.57%
Downside
174.26%
Upside

Inflarx Nv share price movements today

Previous Close: $1.03
Open: $1.01
Volume: 1.4M
Day's Low - High: $0.98 - $1.03
52 Week Low - High: $0.71 - $2.77

Inflarx Nv Historical Returns

1 Month Return: -4.63 %
3 Month Return: -15.57 %
1 Year Return: -56.54 %
3 Year Return: -55.79 %
5 Year Return: -81.96 %

Inflarx Nv Stock Fundamentals & Key Indicators

Check Inflarx Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$69.8M

EPS (TTM)

-0.68

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-47.1M

Revenue (TTM)

62.8K

Profit Margin

0.00%

Return On Equity TTM

-72.49%

Inflarx Nv vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inflarx Nv with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Inflarx Nv	BUY	$69.8M	-81.96%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$48.3B	114.64%	1260.21	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$118.2B	96.7%	32.47	31.35%
Beone Medicines Ltd	NA	$37.8B	NA	669.88	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$79.4B	40.49%	17.95	32.13%

Stock Returns calculator for Inflarx Nv Stock including INR - Dollar returns

The Inflarx Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inflarx Nv investment value today

Current value as on today

₹48,889

Returns

₹51,111

(-51.11%)

Returns from Inflarx Nv Stock

₹57,384 (-57.38%)

Dollar Returns*

₹6,273 (+6.27%)

Analyst Recommendation on Inflarx Nv Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Inflarx Nv. Average target price of $10.41

Inflarx Nv Share Price Target

Get share price movements and forecasts by analysts on Inflarx Nv.

What analysts predicted

90.3%UPSIDE

Target Price

$10.41

Current Price

$1.01

Analyzed by

11 Analysts

Target

$10.41

Inflarx Nv target price $10.41, a slight upside of 90.3% compared to current price of $1.01. According to 11 analysts rating.

Inflarx Nv Stock’s Investor Sentiment and Interest

Search interest for Inflarx Nv Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: December 25, 2025 to January 24, 2026

Change:-57% versus previous 30 day period

Inflarx Nv Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	0	0	0	0	0	0	-	0	0
Gross Profit	0	0	0	0	0	0	-2	0	-2	0
Operating Income	-9	-11	-12	-12	-15	-15	-9	-13	-12	-9
EBITDA	-14	-11	-15	-9	-12	-17	-4	-8	-14	-12
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-7	-15	-9	-12	-17	-5	-8	-14	-12
Income Tax Expense	0	0	0	0	0	0	-	-	-	0
Net Income	-8	-7	-16	-9	-13	-17	-5	-8	-14	-12
Net Profit Margin	0.00%	-12255.00%	-697154.59%	-26798.11%	-217803.07%	-14092.87%	1208456.74%	0.00%	-36559.83%	-51452.32%

Inflarx Nv Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	0	-	-	-	-	-	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	-3
Operating Income	-3	-6	-19	-37	-63	-38	-56	-55	-44	-53
EBITDA	-3	-7	-19	-42	-58	-37	-53	-30	-42	-45
Interest Expense	1	1	2	-	0	0	0	0	0	0
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-4	-8	-24	-29	-59	-38	-53	-30	-42	-46
Income Tax Expense	1	1	2	7	-3	0	0	-2	0	0
Net Income	-5	-9	-28	-33	-66	-47	-60	-32	-46	-48
Net Profit Margin	0.00%	0.00%	-10492.64%	0.00%	0.00%	0.00%	0.00%	0.00%	-67630.69%	-27784.96%

Inflarx Nv Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-7	-15	-9	-13	-17	-5	-8	-14	-12
Operating Cash Flow	-5	-10	-14	-12	-9	-11	-14	-7	-9
Investing Cash Flow	7	2	26	5	17	1	17	-24	2
Financing Cash Flow	0	0	0	0	0	0	27	0	0
Change in Cash	2	-8	12	-5	7	-7	28	-34	-6

Inflarx Nv Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-8	-24	-29	-53	-33	-45	-29	-42	-46
Operating Cash Flow	-4	-12	-23	-43	-36	-39	-33	-37	-48
Investing Cash Flow	0	0	-99	20	21	-25	19	-17	52
Financing Cash Flow	30	108	49	0	9	61	1	52	0
Change in Cash	25	94	-67	-22	-7	0	-9	-3	5

Global Institutional Holdings in Inflarx Nv

Funds	Holdings
CIBC World Markets Inc.	0.04%
Suvretta Capital Management, LLC	9.57%
BOOTHBAY FUND MANAGEMENT, LLC	0.23%
Squarepoint Ops LLC	0.22%
GSA Capital Partners LLP	0.09%

See all

Insights on Inflarx Nv

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 26.0% return, outperforming this stock by 81.8%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 52.5% return, outperforming this stock by 109.0%
NEGATIVE IMPACT
Price Dip
In the last 1 year, IFRX stock has moved down by -56.5%

About Inflarx Nv

inflarx n.v., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using c5a technology primarily in the germany and united states. its c5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. the company's lead product candidate is ifx-1, an intravenously delivered first-in-class anti-c5a monoclonal antibody, which completed the phase iib clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat anca-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of pyoderma gangrenosum, a chronic inflammatory skin disorder, as well as developing ifx-1 for the treatment of oncological diseases. it also develops ifx-2 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. inflarx n.v. has co-development agreement with beijing defe

Organisation	Inflarx Nv
Headquarters	Winzerlaer Str. 2, Jena, Germany, 07745
Industry	Health Technology
CEO	Dr. Niels C. Riedemann M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Inflarx Nv

Name	Title
Dr. Thomas Taapken Ph.D.	Chief Financial Officer
Ms. Derval O'Carroll	Senior VP and Global Head of Regulatory Affairs & Compliance
Mr. Jan Medina CFA	Head of Investor Relations & VP
Mr. Christian Schmid	VP and Head of Legal Affairs & General Counsel
Ms. Nicole Bertsch	Senior Director & Head of Human Resources
Prof. Renfeng Guo M.D.	Co-Founder, Chief Scientific Officer & Executive Director
Dr. Camilla Chong M.D.	Chief Medical Officer
Dr. Maria Habel PH.D.	VP, Head of Preclinical R&D and QC
Mr. Kofi Boaten	VP and Head of Supply Quality & Clinical Trial Supplies
Dr. Niels C. Riedemann M.D., Ph.D.	Co-Founder, CEO & Executive Director

FAQs

What is Inflarx Nv share price today?

Inflarx Nv share price today is $1.01 as on January 24, 2026 at 2:29 am IST at the close of the market. Inflarx Nv share today touched a day high of $1.03 and a low of $0.98.

What is the 52 week high and 52 week low for Inflarx Nv share?

Inflarx Nv share touched a 52 week high of $2.77 on February 13, 2025 and a 52 week low of $0.71 on May 28, 2025. Inflarx Nv stock price today i.e. January 24, 2026 at 2:29 am IST is closed at $1.01,which is 63.54% down from its 52 week high and 41.99% up from its 52 week low.

What is Inflarx Nv's market capitalisation today?

Inflarx Nv market capitalisation is $0.00T as on January 24, 2026 at 2:29 am IST.

How to invest in Inflarx Nv Stock (IFRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inflarx Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inflarx Nv Shares that will get you 1.4851 shares as per Inflarx Nv share price of $1.01 per share as on January 24, 2026 at 2:29 am IST.

What is the minimum amount required to buy Inflarx Nv Stock (IFRX) from India?

Indian investors can start investing in Inflarx Nv (IFRX) shares with as little as ₹91.862 or $1 (as of January 24, 2026 at 4:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹918.62 in Inflarx Nv stock (as per the Rupee-Dollar exchange rate as on January 24, 2026 at 4:37 am IST). Based on Inflarx Nv share’s latest price of $1.01 as on January 24, 2026 at 2:29 am IST, you will get 9.9010 shares of Inflarx Nv. Learn more about fractional shares .

What are the returns that Inflarx Nv has given to Indian investors in the last 5 years?

Inflarx Nv stock has given -81.96% share price returns and 24.87% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?